Dynamics of Interleukin-9 Producing Lymphocytes in Strongyloides ratti-Infected Mice
Pathogens · 2026
DOI: 10.3390/pathogens15030257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Wiebke Hartmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Helminth Immunology, Section Interface, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany. Hauptthemen laut MEDLINE: Interleukin-9, Strongyloidiasis, Strongyloides ratti, Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft DFG, Wellcome Investigator award, German research association DFG.
Abstract (Originalsprache)
Helminths infect a quarter of the human population and are controlled in the frame of a canonical type-2 immune response. Interleukin-9 is a cytokine with pleiotropic functions during type-2 immunity that can be produced by many different cells. Accumulating evidence suggest that IL-9 is of particular relevance in controlling intestinal helminth infections. Using mice infected with the parasitic nematode Strongyloides ratti, we showed previously that ejection from the intestine depends on IL-9 and IL-9-mediated activation of mucosal mast cells. Here we use IL-9 reporter mice to identify the relevant cellular sources of IL-9 in vivo. We report that predominantly CD4+ T cells and group 2 innate lymphoid cells (ILC2s) produced IL-9 in S. ratti-infected or IL-33-treated mice. Interestingly, the IL-33-mediated induction of IL-9 and subsequent mast cell degranulation was modulated by concurrent S. ratti infection. While the IL-33-mediated expansion of IL-9-producing ILC2s was supressed by S. ratti infection, IL-9-producing CD4+ T cells were proportionally increased. Finally, we show that S. ratti-derived E/S products interfered with IL-9 production by BM-derived ILC2 in vitro. In conclusion, we have identified that ILC2 and CD4+ T cells produce IL-9 during S. ratti infection, and that ILC2 responses are suppressed by S. ratti products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helminth Immunology, Section Interface, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
- Departamento de Biología Celular y del Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
- Department of Biology, University Hamburg, 22609 Hamburg, Germany.
ORCID-Profile: Wiebke Hartmann, Lara Linnemann, Minka Breloer
Förderung
- Deutsche Forschungsgemeinschaft DFG
- Wellcome Investigator award
- German research association DFG
Zitieren
APA
Hartmann, W., Heepmann, L., Linnemann, L., Licona-Limon, P., Colomb, F., Frangova, T., McSorley, H. J., & Breloer, M. (2026). Dynamics of Interleukin-9 Producing Lymphocytes in Strongyloides ratti-Infected Mice. Pathogens. https://doi.org/10.3390/pathogens15030257
Vancouver
Hartmann W, Heepmann L, Linnemann L, Licona-Limon P, Colomb F, Frangova T, et al. Dynamics of Interleukin-9 Producing Lymphocytes in Strongyloides ratti-Infected Mice. Pathogens. 2026. doi:10.3390/pathogens15030257
BibTeX
@article{Hartmann2026,
author = {Hartmann, Wiebke and Heepmann, Lennart and Linnemann, Lara and Licona-Limon, Paula and Colomb, Florent and Frangova, Tania and McSorley, Henry J and Breloer, Minka},
title = {Dynamics of Interleukin-9 Producing Lymphocytes in Strongyloides ratti-Infected Mice},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15030257}
}
EUVIMED